Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection
- A. K.A. Wright
- , D. E. Briles
- , D. W. Metzger
- , Stephen Gordon
- Liverpool University Hospitals NHS Foundation Trust
- Liverpool School of Tropical Medicine
- University of Alabama at Birmingham
- Albany Medical College
Research output: Contribution to journal › Review article › peer-review
24
Citations
(Scopus)